Please ensure Javascript is enabled for purposes of website accessibility

Gene test aids cardiac stent patients

Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center now can receive long-term therapy based on information found in their genes.

The medical center is offering a new genetic testing program, at no cost to patients, to help doctors determine which medication a patient should take after a stenting procedure in order to prevent blood clots that could lead to serious — and potentially fatal — heart attacks and strokes.

The tests are available at both UMMC and the Baltimore VA Medical Center, both of which are affiliated with the University of Maryland School of Medicine.